Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Help & FAQ
Link opens in a new tab
Search content at Houston Methodist Scholars
Home
Experts
Research units
Research output
Prizes
View Scopus Profile
Qing Yi, MD, PhD
Ralph O’Connor Centennial Chair
,
Dr. Mary and Ron Neal Cancer Center
Professor of Cancer Biology in Medicine
,
Academic Institute
Member, Research Institute
,
Academic Institute
Charles W. Duncan Jr. Department of Medicine
Associate Director, Cancer Center Basic Research Programs
,
Dr. Mary and Ron Neal Cancer Center
Houston Methodist
Weill Cornell Medical College
h-index
13018
Citations
61
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
1991 …
2025
Research activity per year
Overview
Fingerprint
Network
Research output
(214)
Prizes
(4)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Qing Yi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Multiple Myeloma
95%
Myeloma
71%
Myeloma Cells
59%
T Cells
47%
Idiotype
34%
Dendritic Cells
31%
Myasthenia Gravis
25%
Mantle Cell Lymphoma
22%
Tumor Cells
20%
Tumor Immunity
17%
Th9 Cells
16%
Monoclonal Antibody
15%
Tumor
15%
CD8+ T Cells
14%
β2-microglobulin (β2-MG)
14%
Macrophages
14%
Induced Apoptosis
13%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
12%
Tumor Antigen
11%
B Cells
11%
Bortezomib
11%
Cell-based
11%
Anti-idiotypic
10%
Tumor-specific
10%
B Lymphocytes
10%
Dickkopf-1 (DKK1)
10%
Dectin-1
10%
Lymphoma Cells
9%
Interferon-α (IFN-α)
9%
Interleukin-2
9%
Interleukin-6
9%
Immune System
9%
Bone Marrow
9%
CD4+ T Cells
9%
Monoclonal Gammopathy of Undetermined Significance
8%
MHC Class II
8%
IL-9
8%
Apoptosis
8%
Cytotoxic T Lymphocytes
8%
Tumor Growth
8%
Peripheral Blood
8%
Interleukin-33 (IL-33)
8%
In Cancer
8%
T Cell Response
8%
Acetylcholine Receptor (AChR)
7%
Osteoclast
7%
Hepatocellular Carcinoma
7%
Monoclonal Gammopathy
7%
Cell Survival
7%
Lenalidomide
7%
Immunology and Microbiology
Multiple Myeloma
100%
T Cell
65%
Myeloma Cell
53%
Dendritic Cell
39%
Immunotherapy
35%
Idiotype
31%
In Vitro
25%
Myasthenia gravis
25%
Programmed Cell Death
23%
Cytotoxic T-Cell
23%
B Cell
21%
Monoclonal Antibody
17%
Tumor Cell
17%
Immune Response
16%
Macrophage
16%
Lymphoma Cell
14%
Peptides
14%
Cytotoxic T Cell
12%
Th9 Cell
11%
T-Helper Cell
11%
Tumor Antigen
10%
Acetylcholine
10%
Interleukin 6
10%
Osteoclast
10%
Dectin 1
10%
CD8
9%
Interleukin 2
9%
Monoclonal Immunoglobulinemia
9%
Mouse Model
9%
Immune System
9%
Cytokine
8%
CD4
8%
Drug Resistance
8%
Mitogen
8%
Antineoplastic Activity
8%
Interferon
8%
Secretion (Process)
8%
Osteoclastogenesis
7%
Lenalidomide
7%
Regulatory T Cell
7%
Cell Differentiation
6%
Immunoglobulin Producing Cell
6%
Proteasome
6%
Major Histocompatibility Complex
6%
Mantle Cell Lymphoma Cell
6%
Tumor Immunity
6%
T Cell Subset
5%
Cancer Immunotherapy
5%
Granulocyte Macrophage Colony-Stimulating Factor
5%
Myeloma Cell Line
5%
Medicine and Dentistry
Multiple Myeloma
48%
Myeloma
29%
T Cell
24%
Myeloma Cell
20%
Dendritic Cell
16%
Immunoglobulin Idiotype
16%
Tumor
16%
Immunotherapy
13%
Neoplasm
13%
Tumor Cell
12%
Cytotoxic T-Cell
12%
Mantle Cell Lymphoma
12%
In Vitro
8%
B Cell
8%
Monoclonal Gammopathy of Undetermined Significance
7%
Mantle Cell Lymphoma Cell
7%
Programmed Cell Death
7%
Th9 Cell
6%
T-Helper Cell
6%
Specific Tumor
6%
Cancer
6%
T-Cell Response
5%
Mitogen Activated Protein Kinase P38
5%
p38 Mitogen-Activated Protein Kinase
5%
Diseases
5%
